Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period-Reference-Cited by-同舟云学术

Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period

Published:2018-11 Issue:9 Volume:50 Page:2684-2689
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Kato H.,Usui M.,Muraki Y.,Okuda M.,Nakatani K.,Hayasaki A.,Ito T.,Iizawa Y.,Murata Y.,Tanemura A.,Kuriyama N.,Azumi Y.,Kishiwada M.,Mizuno S.,Sakurai H.,Isaji S.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference17 articles.

1. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients;Uesugi;Pharmacogenet Genomics,2006

2. CYP3A5* 1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation;Goto;Pharmacogenet Genomics,2004

3. Long-term influence of CYP3A5 gene polymorphism on pharmacokinetics of tacrolimus and patient outcome after living donor liver transplantation;Kato;Transplant Proc,2016

4. Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients;Mizuno;Ann Transplant,2013

5. Banff schema for grading liver allograft rejection: an international consensus document;Hepatology,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation;Frontiers in Pharmacology;2024-01-08

2. Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches;Pharmacogenomics;2021-11

3. Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized Medicine;Current Drug Metabolism;2021-10

4. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation;European Journal of Drug Metabolism and Pharmacokinetics;2020-06-08

5. Importance of genetic polymorphisms in liver transplantation outcomes;World Journal of Gastroenterology;2020-03-28